<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikimesothelioma.com/w/index.php?action=history&amp;feed=atom&amp;title=Gene_Therapy</id>
	<title>Gene Therapy - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikimesothelioma.com/w/index.php?action=history&amp;feed=atom&amp;title=Gene_Therapy"/>
	<link rel="alternate" type="text/html" href="https://wikimesothelioma.com/w/index.php?title=Gene_Therapy&amp;action=history"/>
	<updated>2026-04-10T18:31:58Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.45.1</generator>
	<entry>
		<id>https://wikimesothelioma.com/w/index.php?title=Gene_Therapy&amp;diff=2087&amp;oldid=prev</id>
		<title>MesotheliomaSupport: Fix broken internal link: Pleurectomy Decortication→Pleurectomy and Decortication; remove orphaned ref pmcimmunotherapy</title>
		<link rel="alternate" type="text/html" href="https://wikimesothelioma.com/w/index.php?title=Gene_Therapy&amp;diff=2087&amp;oldid=prev"/>
		<updated>2026-04-06T09:18:30Z</updated>

		<summary type="html">&lt;p&gt;Fix broken internal link: Pleurectomy Decortication→Pleurectomy and Decortication; remove orphaned ref pmcimmunotherapy&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 09:18, 6 April 2026&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l513&quot;&gt;Line 513:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 513:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* [[TTFields_Optune_Lua|TTFields / Optune Lua for Mesothelioma]]&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* [[TTFields_Optune_Lua|TTFields / Optune Lua for Mesothelioma]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* [[VATS_and_Thoracoscopic_Procedures|VATS and Thoracoscopic Procedures]]&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* [[VATS_and_Thoracoscopic_Procedures|VATS and Thoracoscopic Procedures]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* [[&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Pleurectomy_Decortication&lt;/del&gt;|Pleurectomy/Decortication]]&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* [[&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Pleurectomy and Decortication&lt;/ins&gt;|Pleurectomy/Decortication]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* [[Extrapleural_Pneumonectomy|Extrapleural Pneumonectomy]]&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* [[Extrapleural_Pneumonectomy|Extrapleural Pneumonectomy]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* [[Asbestos_Trust_Fund_Quick_Reference|Asbestos Trust Fund Quick Reference]]&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* [[Asbestos_Trust_Fund_Quick_Reference|Asbestos Trust Fund Quick Reference]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l554&quot;&gt;Line 554:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 554:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;ref name=&amp;quot;ascosurvival&amp;quot;&amp;gt;[https://ascopubs.org/doi/10.1200/JCO.2022.40.16_suppl.8561 Final survival outcomes and immune biomarker analysis of ONCOS-102 in mesothelioma], Journal of Clinical Oncology (2022)&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;ref name=&amp;quot;ascosurvival&amp;quot;&amp;gt;[https://ascopubs.org/doi/10.1200/JCO.2022.40.16_suppl.8561 Final survival outcomes and immune biomarker analysis of ONCOS-102 in mesothelioma], Journal of Clinical Oncology (2022)&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;ref name=&amp;quot;circiotargovax&amp;quot;&amp;gt;[https://www.circio.com/en/targovax-recruits-the-first-patient-in-a-trial-with-the-oncolytic-virus-oncos-102-in-malignant-pleural-mesothelioma/ Targovax Recruits First Patient in ONCOS-102 Mesothelioma Trial], Circio (Targovax)&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;ref name=&amp;quot;circiotargovax&amp;quot;&amp;gt;[https://www.circio.com/en/targovax-recruits-the-first-patient-in-a-trial-with-the-oncolytic-virus-oncos-102-in-malignant-pleural-mesothelioma/ Targovax Recruits First Patient in ONCOS-102 Mesothelioma Trial], Circio (Targovax)&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;ref name=&quot;pmcimmunotherapy&quot;&amp;gt;[https://pmc.ncbi.nlm.nih.gov/articles/PMC7082257/ Immunotherapy for mesothelioma: a critical review of current clinical trials], PMC (2020)&amp;lt;/ref&amp;gt;&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-added&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;ref name=&amp;quot;nyugelsinger&amp;quot;&amp;gt;[https://med.nyu.edu/departments-institutes/population-health/divisions-sections-centers/medical-ethics/education/high-school-bioethics-project/learning-scenarios/jesse-gelsinger-case Gene Therapy Research &amp;amp; the Case of Jesse Gelsinger], NYU Langone Medical Ethics&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;ref name=&amp;quot;nyugelsinger&amp;quot;&amp;gt;[https://med.nyu.edu/departments-institutes/population-health/divisions-sections-centers/medical-ethics/education/high-school-bioethics-project/learning-scenarios/jesse-gelsinger-case Gene Therapy Research &amp;amp; the Case of Jesse Gelsinger], NYU Langone Medical Ethics&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;ref name=&amp;quot;scihistgelsinger&amp;quot;&amp;gt;[https://www.sciencehistory.org/stories/magazine/the-death-of-jesse-gelsinger-20-years-later/ The Death of Jesse Gelsinger, 20 Years Later], Science History Institute&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;ref name=&amp;quot;scihistgelsinger&amp;quot;&amp;gt;[https://www.sciencehistory.org/stories/magazine/the-death-of-jesse-gelsinger-20-years-later/ The Death of Jesse Gelsinger, 20 Years Later], Science History Institute&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>MesotheliomaSupport</name></author>
	</entry>
	<entry>
		<id>https://wikimesothelioma.com/w/index.php?title=Gene_Therapy&amp;diff=1685&amp;oldid=prev</id>
		<title>MesotheliomaSupport: Publish comprehensive Gene Therapy medical wiki page — HSV-tk, interferon (TR002 Phase 3), ONCOS-102, TUSC2/Reqorsa, CRISPR, clinical trial timeline, safety profile</title>
		<link rel="alternate" type="text/html" href="https://wikimesothelioma.com/w/index.php?title=Gene_Therapy&amp;diff=1685&amp;oldid=prev"/>
		<updated>2026-03-04T03:01:58Z</updated>

		<summary type="html">&lt;p&gt;Publish comprehensive Gene Therapy medical wiki page — HSV-tk, interferon (TR002 Phase 3), ONCOS-102, TUSC2/Reqorsa, CRISPR, clinical trial timeline, safety profile&lt;/p&gt;
&lt;a href=&quot;https://wikimesothelioma.com/w/index.php?title=Gene_Therapy&amp;amp;diff=1685&quot;&gt;Show changes&lt;/a&gt;</summary>
		<author><name>MesotheliomaSupport</name></author>
	</entry>
</feed>